References
- Prince M, Wimo A, Guerchet M, et al. World Alzheimer report. London, UK: Alzheimer’s Disease International; 2015.
- Wittenberg R, Knapp M, Hu B, et al. The costs of dementia in England. Int J Geriatr Psychiatry. 2019;34(7):1095–1103.
- Handels RLH, Sköldunger A, Bieber A, et al.; Actifcare consortium. Quality of life, care resource use, and costs of dementia in 8 European countries in a cross-sectional cohort of the Actifcare study. J Alzheimers Dis. 2018;66(3):1027–1040.
- Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med. 2004;256:183–194.
- Yohannes AM, Chen W, Moga AM, et al. Cognitive impairment in chronic obstructive pulmonary disease and chronic heart failure: A systematic Review and Meta-analysis of observational studies. J Am Med Dir Assoc. 2017;18(5):451.e1–451.e11.
- Ozyemisci-Taskiran O, Bozkurt SO, Koktruck N, et al. Is there any association between cognitive status and functional capacity during exacerbation of chronic obstructive pulmonary disease. Chron Respir Dis. 2015;12:247–255.
- Karmanali H, Hik F, Kayhan F, et al. Assessment of cognitive impairment in long-term oxygen therapy dependent COPD patients. Int J Chron Obstruct Pulmon Dis. 2015;10:2087–2094.
- Martinez CH, Richardson CR, Han MK, et al. Chronic obstructive pulmonary disease, cognitive impairment, and development of disability. The health and retirement study. Ann Am Thorac Soc. 2014;11:1222–1230.
- Dodd JW, Novotrny P, Schurba FC, et al. NETT Research group. Executive function, survival and hospitalization in chronic obstructive pulmonary disease. A longitudinal analysis of the National Emphysema Treatment Trial (NETT). Ann Am Thorac Soc. 2015;12:1473–1481.
- Cleutjens FAHM, Spruit MA, Ponds RWHM, et al. The impact of cognitive impairment on efficacy of pulmonary rehabilitation in patients with COPD. J Am Med Dir Assoc. 2017;18(5):420–426.
- Xie F, Xie L. COPD and the risk of mild cognitive impairment and dementia: a cohort study based on the Chinese longitudinal health longitudinal survey. Int J Chron Obstruct Pulmon Dis. 2019;14:403–408.
- Folstein MF, Folstein SE, McHugh PR. ‘Mini-mental state’: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–198.
- Hodkinson HM. Evaluation of a mental test score for assessment of mental impairment in the elderly. Age Ageing. 1972;1:35–40.
- Nasreddine ZS, Phillips NA, Bédirian V, et al. The Montreal cognitive assessment, MoCA: A brief screening tool for mild cognitive impairment. J Am Geriatric Soc. 2005;53(4):695.
- Dulhorey MM, Schorder DR, Benzo RP. Cognitive function and living situation in COPD. Is there a relationship with self-management and quality of life? Int J Chron Obstruct Pulm Dis. 2015;10:1883–1889.
- Baker AM, Holbrook JT, Yohannes AM, et al.; for American Lung Association Airways Clinical Research Centers. Test performance characteristics of the AIR, GAD-7 and HADS-anxiety screening questionnaires for anxiety in chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2018;15(8):926–934.
- Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S population. Am J Respir Crit Care Med. 1999;159(1):179–187.
- American Thoracic Society. ATS statement: guidelines for six minute walk test. Am J Respir Crit Care Med. 2002;166:111–117.
- Jones PW, Harding G, Berry P, et al. Development and first validation of the COPD assessment test. Eur Respir J. 2009;34:648–654.
- Bestall JC, Paul EA, Garrod R, et al. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54:581–586.
- Willgoss TG, Goldbart J, Fatoye F, et al. The development and validation of the anxiety inventory for respiratory disease. Chest. 2013;144:1587–1596.
- Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361–370.
- Kertz S, Bigda-Peyton J, Bjorgvinsson T. Validity of the generalized anxiety disorder-7 scale in an acute psychiatric sample. Clin Psychol Psychother. 2013;20(5):456–464.
- Kronke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–613.
- Craig BM, Reeve BB, Brown PM, et al. US valuation of health outcomes measured using the PROMIS-29. Value Health. 2014;17:846–853.
- Herdman M, Gudex C, Lloyd A, et al. Development and preliminary testing of the new five‐level version of EQ‐5D (EQ‐5D‐5L). Qual Life Res. 2011;20:1727–1736.
- Buysse DJ, Reynold CF, Monk TH, et al. The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28(2):193–213.
- Boyle PA, Yu L, Wilson RS, et al. Cognitive decline impairs financial and health literacy among community-based older persons without dementia. Psychol Aging. 2013;28(3):614–624.
- Goldestein FC, Ashley AV, Miller E, et al. Validity of the montreal cognitive assessment as a screen for mild cognitive impairment and dementia in African Americans. J Geriatr Psychiatry Neurol. 2014;27(3):199–203.
- Lourida I, Hannon E, Littlejohns TJ, et al. Association of lifestyle and genetic risk with incidence of dementia. JAMA. 2019;322(5):430–437.
- Lopez-Torres I, Valenza MC, Torres-Sanchez I, et al. Changes in cognitive status in COPD patients across clinical stages. COPD. 2016;13(3):327–332.
- Dag E, Bulcun E, Turkel Y, et al. Factors influencing cognitive function in subjects with COPD. Respir Care. 2016;61(8):1044–1050.
- Yohannes AM, Mullerova H, Hanania NA, et al. Long-term course of depression trajectories in patients with COPD: A 3-year follow-up analysis of the evaluation of COPD longitudinally to identify predictive surrogate endpoints cohort. Chest. 2016;149(4):916–926.
- Park SK. Trajectories of change in cognitive function in people with chronic obstructive pulmonary disease. J Clin Nurs. 2018;27(7–8):1529–1542.
- Pierobon A, Ranzini L, Torlaschi V, et al. Screening for neuropsychological impairment in COPD patients undergoing rehabilitation. PLoS One. 2018;13(8):e0199736.